IRIS
SACCANI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.535
AS - Asia 1.858
EU - Europa 1.482
SA - Sud America 229
AF - Africa 93
Continente sconosciuto - Info sul continente non disponibili 50
OC - Oceania 1
Totale 6.248
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.465
CN - Cina 613
SG - Singapore 565
FI - Finlandia 344
VN - Vietnam 294
SE - Svezia 288
IE - Irlanda 231
BR - Brasile 172
IT - Italia 143
DE - Germania 132
HK - Hong Kong 120
UA - Ucraina 74
BD - Bangladesh 69
TR - Turchia 59
FR - Francia 58
ZA - Sudafrica 55
GB - Regno Unito 49
CA - Canada 48
NL - Olanda 45
IN - India 36
AT - Austria 33
AR - Argentina 27
ES - Italia 17
BE - Belgio 16
CI - Costa d'Avorio 15
EC - Ecuador 14
JP - Giappone 14
MX - Messico 13
PH - Filippine 13
RU - Federazione Russa 13
CZ - Repubblica Ceca 12
ID - Indonesia 9
IQ - Iraq 9
PK - Pakistan 9
PL - Polonia 8
TH - Thailandia 8
CO - Colombia 7
LT - Lituania 7
KR - Corea 6
EG - Egitto 5
EU - Europa 5
MA - Marocco 5
TW - Taiwan 5
ET - Etiopia 4
LB - Libano 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CR - Costa Rica 3
KE - Kenya 3
SN - Senegal 3
AL - Albania 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
KG - Kirghizistan 2
MY - Malesia 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
GY - Guiana 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SX - ???statistics.table.value.countryCode.SX??? 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.205
Salva come PNG Salva come JPEG
Città #
Singapore 320
Ashburn 310
Chandler 277
Dublin 231
San Jose 193
Santa Clara 171
Beijing 155
Dallas 131
Hong Kong 111
Dearborn 95
Jacksonville 95
Ho Chi Minh City 93
New York 92
Boardman 84
Parma 81
Council Bluffs 70
Nanjing 65
Shanghai 63
Hanoi 58
Munich 53
Johannesburg 52
Ann Arbor 48
Izmir 44
Los Angeles 40
Princeton 38
Lauterbourg 34
Vienna 29
Buffalo 28
Helsinki 25
Wilmington 24
San Mateo 23
Nanchang 22
Kunming 20
Toronto 20
Hebei 18
Bremen 16
Brussels 16
Jinan 16
Seattle 16
Abidjan 15
Montreal 15
São Paulo 15
Des Moines 14
Guangzhou 14
Haiphong 14
Hefei 14
London 12
Tokyo 12
Brooklyn 11
Houston 11
Phoenix 11
Pune 11
Shenyang 11
Tianjin 10
Turku 10
Brno 9
Changsha 9
Denver 9
Zhengzhou 9
Chicago 8
Hangzhou 8
Jiaxing 8
Milan 8
Norwalk 8
Poplar 8
Stockholm 8
Warsaw 8
Bắc Ninh 7
Da Nang 7
Dhaka 7
Ottawa 7
Rio de Janeiro 7
Atlanta 6
Can Tho 6
Chennai 6
Frankfurt am Main 6
Guayaquil 6
Hải Dương 6
New Delhi 6
Washington 6
Bangkok 5
Boston 5
Columbus 5
Manchester 5
Marseille 5
Moscow 5
Rome 5
Ankara 4
Augusta 4
Bến Tre 4
Chengdu 4
Erbil 4
Fremont 4
Quito 4
Redondo Beach 4
Woodbridge 4
Addis Ababa 3
Baghdad 3
Baku 3
Biên Hòa 3
Totale 3.743
Salva come PNG Salva come JPEG
Nome #
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 229
Targeting PI3K somatic mutations reduces invasion and EMT in squamous cell carcinoma of the lung 213
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 207
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 203
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines 199
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification 187
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 185
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 185
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 183
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 182
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 180
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 180
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 179
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 178
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer 175
5-HT1A receptors as target to protect the intestine in an experimental model of colitis 171
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 171
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 169
Analgesic activity of new hybrid muscarinic agonists in mice 169
Dual role of endogenous serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-induced colitis 167
Effect of specific PI3K/mTOR inhibitors in squamous lung cancer cells carrying PI3K alterations 167
Effects of FGFR1 inhibition on survival, proliferation, and energy metabolism in Non Small Cell Lung Cancer (NSCLC) cell lines 163
Effect of μ Opioid Receptor Activation On Intestinal Ischemia/Reperfusion Injury in Mice 162
Erlotinib enhances antibody-dependent cellular cytotoxicity of wil-type erlotinib-sensitive NSCLC cell lines 160
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 158
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 157
Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. 153
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 153
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 149
Activation of μ opioid receptors ameliorates mucosal injury induced by intestinal ischemia and reperfusion in mice 147
Radiological analysis of gastrointestinal dysmotility associated with central dopaminergic impairment in an animal model of parkinson's disease (PD) 142
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 140
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 136
Pharmacological modulation of 5HT1A receptors in mice mesenteric ischemia/reperfusion injury: protective effect of Buspirone and WAY100135 125
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 114
T-DM1: a new therapeutic approach in HER-2 overexpressing NSCLC cell lines 112
Protective role of μ opioid receptor activation in intestinal inflammation induced by mesenteric ischemia/reperfusion in mice. 104
Pharmacological characterization of a new non-himidazole histamine H3 antagonist 94
Totale 6.248
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.325
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022169 0 0 0 24 6 3 23 21 8 10 9 65
2022/2023971 116 130 61 85 81 112 23 38 266 2 46 11
2023/2024330 15 18 4 12 23 92 32 35 18 6 25 50
2024/2025906 26 44 51 63 100 100 32 31 119 74 84 182
2025/20262.190 275 170 204 248 307 142 182 65 315 148 64 70
2026/2027341 53 117 102 69 0 0 0 0 0 0 0 0
Totale 6.248